Search

everythinglearnresearchcommunity

for

Search:↓

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Different treatments for PCOS focus on the specific symptoms, with weight loss and lifestyle changes being important.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Microspheres about 1.5 micrometers in size can best penetrate hair follicles, potentially reaching important stem cells.

TRPA1 is crucial for mechanical sensitivity in skin sensory neurons.

Adding chemotherapy to tamoxifen improves survival for older breast cancer patients with positive nodes.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Hidradenitis suppurativa, a chronic skin disease, can be managed with antibiotics, lifestyle changes, and in severe cases, surgery. Early diagnosis and careful planning are key, and laser treatment can be an efficient solution for mild to severe cases.

Cyproterone acetate is effective for acne but less so for hirsutism and alopecia, with some side effects and quick menstrual cycle recovery after treatment.

Older adults diagnosed with lupus show less severe symptoms but have a lower survival rate, often due to age-related factors.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Radiation therapy with a higher dose for the brain improves survival in cerebellar medulloblastoma.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Bioprinting could improve wound healing but needs more development to match real skin.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Forehead modification greatly increases the perception of femininity and is a safe procedure.